Treasury union on FDA lab closures
This article was originally published in The Tan Sheet
The National Treasury Employees Union announces Feb. 12 it sent a letter to Rep. John Dingell, D-Mich., and Rep. Bart Stupak, D-Mich., to halt proposed FDA Office of Regulatory Affairs lab closures. NTEU President Colleen M. Kelley says in a release the lab closures would compromise food safety. Kelley also says she disapproves of FDA's lack of communication with its employees, "I find it particularly egregious that the agency would let corrosive rumors about closings and consolidations spread throughout the workplace." NTEU's letter follows on the heels of a letter 20 senators sent to FDA Commissioner Andrew C. von Eschenbach in January, saying the lab closures should undergo a congressional review (1"The Tan Sheet," Feb. 5, 2007, p. 13)...
You may also be interested in...
The Office of Regulatory Affairs' plan to close FDA labs should "undergo congressional review" according to a letter 20 senators sent to Commissioner Andrew von Eschenbach Jan. 30
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.
Perrigo will launch generics of GSK's OTC Voltaren Arthritis Pain drug later in 2020 following FDA approval of its ANDA. GSK, which received FDA's OTC switch approval in February, still hasn't launched the product or indicated when it will.